Usefulness and difficulties with the thiopurine pharmacogenomic NUDT15 genotyping test: Analysis of real-world data in Japan
Authors:
Open Access
- 11 September 2023
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 153 (3) , 161-169
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicityNature Genetics, 2016
- NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBDThe Pharmacogenomics Journal, 2015
- Susceptibility to 6‐MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemiaBritish Journal of Haematology, 2015
- Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has comeJournal of Clinical Pathology, 2010
- Adverse reactions to azathioprine cannot be predicted by thiopurine S‐methyltransferase genotype in Japanese patients with inflammatory bowel diseaseJournal of Gastroenterology and Hepatology, 2009
- Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatmentJournal of Gastroenterology, 2009
- Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activityPharmacogenetics and Genomics, 2008
- TPMT genotype and the use of thiopurines in paediatric inflammatory bowel diseaseDigestive and Liver Disease, 2005
- Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspectsEuropean Journal of Cancer, 2005
- Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitisJournal of Gastroenterology, 2003